Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fleming

Showing results (401-410 of 437) with videos related to

Pageof 44
Sort By:
Gynecologic Oncology|July 2, 2025
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIOMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Neurology|May 7, 2026
Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down SyndromePaul A Chung, Victoria L Fleming, Kathryn J Reid, et al.
Npj Mental Health Research|April 12, 2024
A computational approach to measure the linguistic characteristics of psychotherapy timing, responsiveness, and consistencyAdam S Miner, Scott L Fleming, Albert Haque, et al.
Analytical Biochemistry|December 19, 2009
A fluorescent assay suitable for inhibitor screening and vanin tissue quantificationBenfang H Ruan, Derek C Cole, Paul Wu, et al.
Oncotarget|January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomasSasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Journal of Geophysical Research. Atmospheres : JGR|February 23, 2016
Measuring and modeling the lifetime of nitrous oxide including its variabilityMichael J Prather, Juno Hsu, Nicole M DeLuca, et al.
Gynecologic Oncology|June 11, 2022
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumabMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
American Journal of Rhinology|January 12, 1999
Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass seasonR Rosenthal, W Berger, E Bronsky, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|November 4, 2022
MRI ischemic and hemorrhagic lesions in arterial and venous territories characterize central nervous system intravascular lymphoma in dogsChiara Mattei, Anna Oevermann, Daniela Schweizer, et al.
Pageof 44

Showing results (401-410 of 437) with videos related to

Sort By:
Pageof 44
Gynecologic Oncology|July 2, 2025
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIOMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Neurology|May 7, 2026
Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down SyndromePaul A Chung, Victoria L Fleming, Kathryn J Reid, et al.
Npj Mental Health Research|April 12, 2024
A computational approach to measure the linguistic characteristics of psychotherapy timing, responsiveness, and consistencyAdam S Miner, Scott L Fleming, Albert Haque, et al.
Analytical Biochemistry|December 19, 2009
A fluorescent assay suitable for inhibitor screening and vanin tissue quantificationBenfang H Ruan, Derek C Cole, Paul Wu, et al.
Oncotarget|January 17, 2019
Oncogenic <i>transgelin-2</i> is differentially regulated in <i>isocitrate dehydrogenase</i> wild-type vs. mutant gliomasSasha J Beyer, Erica H Bell, Joseph P McElroy, et al.
Journal of Geophysical Research. Atmospheres : JGR|February 23, 2016
Measuring and modeling the lifetime of nitrous oxide including its variabilityMichael J Prather, Juno Hsu, Nicole M DeLuca, et al.
Gynecologic Oncology|June 11, 2022
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumabMelissa M Hardesty, Thomas C Krivak, Gail S Wright, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
American Journal of Rhinology|January 12, 1999
Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass seasonR Rosenthal, W Berger, E Bronsky, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|November 4, 2022
MRI ischemic and hemorrhagic lesions in arterial and venous territories characterize central nervous system intravascular lymphoma in dogsChiara Mattei, Anna Oevermann, Daniela Schweizer, et al.
Pageof 44